Table 4.
Percent prevalence of HBV infection in patients of different diseases in Pakistan.
| Population type | Region | Methods | Population size | HBV positive(%) | HBV marker | Reference |
|---|---|---|---|---|---|---|
| Surgical patients | Karachi | EIA | 496 | 5.0% | HBsAg | Moosa et al. [57] 2009 |
| Jacobabad Sindh | ICT | 150 | 9.33% | HBsAg | Daudpota & Soomro, [58] 2008 | |
| Karachi | ELISA | 387 | 6.5% | HBsAg | Masood et al. [59] 2005 | |
| Karachi | Latex method, ELISA | 411 | 8.76% | HBsAg | Shirazi et al. [60] 2004 | |
| Patients with cirrhosis | Saidu Sharif, Swat | ELISA | 110 | 21.81% | HBsAg | Khan et al. [62] 2009 |
| Dera Ismail Khan | ICT | 60 | 46.67% | HBsAg | Mashud et al. [63] 2004 | |
| Lahore | ICT, ELISA | 94 | 23% | HBsAg, anti-HBcIgG, anti-HBs, and HBeAg | Khan et al. [64] 2002 | |
| Lahore | ELISA | 50 | 24% | HBsAg | Hussain et al. [65] 1998 | |
| Patients with Hepatocellular carcinoma (HCC) | Hyderabad | ELISA | 200 | 21.0% | HBsAg | Ansari et al. [66] 2009 |
| Rawalpindi | ICT, ELISA | 44 | 25% | anti-HBsAg, anti-HBcAb antiHBeAb | Mumtaz et al. [67] 2001 | |
| Lahore | ELISA | 30 | 20% | HBsAg | Kausar et al. [68] 1998 | |
| Patients with hepatitis | Rawalpindi | ICT | 264 | 9.8% | HBsAg | Mumtaz & Aftab [69] 2005 |
| Hyderabad/Jamshoro | ELISA | 100 | 41% | anti-HBs anti-HBc |
Almani et al. [70] 2002 | |
| Islamabad | ELISA | 2574 | 15% | HBsAg | Tanwani & Ahmad [71] 2000 | |
| Karachi | MEIA-Abbott | 1225 | 2% | HBsAg | Mahmood [72] 2000 | |
| Rawalpindi | RPHA or ELISA | 4315 | 11.68% | HBsAg | Hussain & Ahmed [73] 1998 |
|
| Patients of Liver disease | Karachi | ICT, ELISA, PCR | 5193 | 32.6% | HBsAg | Ahmed et al. [74] 2010 |
| Peshawar | ICT, ELISA and PCR. | 181 | 18.23% | HBs Ag or DNA | Khan [75] 2006 | |
| Faisalabad | ELISA | 100 | 29% | HBsAg | Bilal et al. [76] 2006 | |
| Hazara Division | ICT | 893 | 30.35% | HBsAg | Khan and Rizvi [77] 2003 | |
| MTP (Thalassemic & Hemophiliac Children) | Islamabad | ICT, ELISA | 251 | 3.9% | HBsAg | Burki et al. [79] 2009 |
| Peshawar | ELISA | 250 | 8.4% | HBsAg | Shah et al. [80] 2005 | |
| Peshawar | ELISA | 80 | 7.591 | HBsAg | Mohammad et al. [81] 2003 | |
| Peshawar | ELISA | 40 | 5% | HBsAg | Hussain et al. [82] 2003 | |
| Ophthalmic Patients | Jamshoro/Hyderabad | ICT | 931 | 4.6% | HBsAg | Junejo et al. [88] 2009 |
| Dera Ismail Khan | ICT, ELISA | 1130 | 3.18% | HBsAg | Ahmad et al. [89] 2006 | |
| IDU | Peshawar | ELISA | 250 | 22.4% | HBsAg | Alam et al. [86] 2007b |
| Karachi | ELISA | 161 | 7.5% | HBsAg | Altaf et al. [87] 2007 |
MTP: Multi-transfused Population, IDU: Injecting drug Users